Adrenocorticotropic hormone-independent hypercortisolism is more prevalent in T2D with obesity than in obesity with or ...
OVERLAND PARK, Kan. , May 19, 2026 /PRNewswire/ -- Dechra is proud to announce the U.S. Food and Drug Administration's (FDA) approval of CosACTHen® (cosyntropin injection), the first and only ...
CosACTHen by Dechra is indicated for the evaluation of adrenal function in dogs. The FDA has approved the first cosyntropin indicated for canine diagnostic use. The approved cosyntropin injection ...
WASHINGTON — The U.S. Army today announced the implementation of the new Combat Field Test (CFT), a major update to its physical readiness program designed to align fitness standards with the ...
We prospectively enrolled 72 adults with overweight or obesity and mild hypertension (0–1 antihypertensive), free of known cardiovascular disease, in a mechanistic ...
The Centers for Disease Control and Prevention (CDC) has paused its diagnostic testing for a host of infectious diseases, including rabies. The CDC on Monday posted a list of 27 tests that it either ...
A social media post from the US Food and Drug Administration this week shows a big-eyed macaque staring out from behind bars. “Some drugs use 144 monkeys on average for preclinical testing,” the post ...
Lee Zeldin, the E.P.A. administrator, revived a plan created during the first Trump administration to end the testing of chemicals on mammals. By Lisa Friedman The Environmental Protection Agency will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results